Lv6
1720 积分 2023-12-22 加入
PET/CT-Guided Neoadjuvant Tislelizumab Plus Chemotherapy/Chemoradiotherapy for Resectable Esophageal Squamous Cell Carcinoma: RATIONALE-213 Final Analysis
3天前
求助中
Phase Ib study of anlotinib in combination with anti-PD-L1 antibody (TQB2450) in patients with advanced acral melanoma
1个月前
已完结
Real-World Outcomes of Patients Treated With Gemcitabine Using Standardized Dose and Rate and Docetaxel for Advanced Soft Tissue Sarcoma in an Australian Sarcoma Center
4个月前
已完结
Apatinib with doxorubicin and ifosfamide as neoadjuvant therapy for high-risk soft tissue sarcomas: a retrospective cohort study
4个月前
已完结
A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma
4个月前
已完结
Multicenter, Randomized, Phase III Trial of Neoadjuvant Chemoradiation With Capecitabine and Irinotecan Guided by UGT1A1 Status in Patients With Locally Advanced Rectal Cancer
4个月前
已完结
Sintilimabplusanlotinibinpatientswithpre-treatedlocallyadvancedormetastaticsarcoma:aprospectivesingle-armphaseIIclinicaltrial
5个月前
已完结
First-Line of Anlotinib Plus Anthracyclines and Ifosfamide Followed by Anlotinib Maintenance in Advanced Soft Tissue Sarcoma: A Phase II Single-Arm Trial
5个月前
已完结
皖公网安备34019202002308
